Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.

Nicholson LK, Pratap H, Bowers E, Gunzburger E, Bandi SR, Gardner EM, Palmer BE, Wright T, Kittelson J, Janoff EN.

Immunobiology. 2018 Dec;223(12):839-849. doi: 10.1016/j.imbio.2018.08.007. Epub 2018 Sep 7.

PMID:
30219203
2.

Feasibility of a targeted strengthening program to improve gait in people with multiple sclerosis: a brief report.

Mañago MM, Hebert JR, Kittelson J, Schenkman M.

Int J Rehabil Res. 2018 Dec;41(4):364-367. doi: 10.1097/MRR.0000000000000306.

PMID:
30044244
3.

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).

Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WR.

Am Heart J. 2018 May;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3.

PMID:
29754671
4.

Contributions of Ankle, Knee, Hip, and Trunk Muscle Function to Gait Performance in People With Multiple Sclerosis: A Cross-Sectional Analysis.

Mañago MM, Hebert JR, Kittelson J, Schenkman M.

Phys Ther. 2018 Jul 1;98(7):595-604. doi: 10.1093/ptj/pzy048.

PMID:
29660080
5.

Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial.

Schwartz GG, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Nicholls SJ, Olsson AG, Shah PK, Tardif JC, Kittelson J.

JAMA Cardiol. 2018 Feb 1;3(2):164-168. doi: 10.1001/jamacardio.2017.3833.

6.

Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.

Chi G, Goldhaber SZ, Kittelson JM, Turpie AGG, Hernandez AF, Hull RD, Gold A, Curnutte JT, Cohen AT, Harrington RA, Gibson CM.

J Thromb Haemost. 2017 Oct;15(10):1913-1922. doi: 10.1111/jth.13783. Epub 2017 Sep 4.

7.

Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.

Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, Nicholls SJ, Shah PK, Tardif JC, Olsson AG, McMurray JJ, Kittelson J, Schwartz GG.

J Am Heart Assoc. 2017 Jan 10;6(1). pii: e004119. doi: 10.1161/JAHA.116.004119.

8.

Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.

Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Nicholls SJ, Niesor EJ, Olsson AG, Shah PK, Tardif JC, Kittelson J, Schwartz GG.

J Am Coll Cardiol. 2016 Dec 6;68(22):2488-2490. doi: 10.1016/j.jacc.2016.09.932. No abstract available.

9.

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation.

Kittelson JM, Steg PG, Halperin JL, Goldenberg NA, Schulman S, Spyropoulos AC, Kessler CM, Turpie AG, Cutler NR, Hiatt WR; Antithrombotic Trials Leadership and Steering (ATLAS) Group.

Thromb Haemost. 2016 Aug 30;116(3):544-53. doi: 10.1160/TH15-12-1000. Epub 2016 Jun 23.

PMID:
27346176
10.

Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities.

Goldenberg NA, Takemoto CM, Yee DL, Kittelson JM, Massicotte MP.

Blood. 2015 Dec 10;126(24):2541-7. doi: 10.1182/blood-2015-06-651539. Epub 2015 Oct 23.

PMID:
26500341
11.

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.

Goldenberg NA, Abshire T, Blatchford PJ, Fenton LZ, Halperin JL, Hiatt WR, Kessler CM, Kittelson JM, Manco-Johnson MJ, Spyropoulos AC, Steg PG, Stence NV, Turpie AG, Schulman S; Kids-DOTT Trial Investigators.

J Thromb Haemost. 2015 Sep;13(9):1597-605. doi: 10.1111/jth.13038. Epub 2015 Aug 11.

12.

Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study.

Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS.

Dement Geriatr Cogn Dis Extra. 2015 Feb 20;5(1):51-63. doi: 10.1159/000371509. eCollection 2015 Jan-Apr.

13.

Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment.

Shea KL, Gavin KM, Melanson EL, Gibbons E, Stavros A, Wolfe P, Kittelson JM, Vondracek SF, Schwartz RS, Wierman ME, Kohrt WM.

Menopause. 2015 Oct;22(10):1045-52. doi: 10.1097/GME.0000000000000430. Erratum in: Menopause. 2018 Mar;25(3):359.

14.

Timing of Ibuprofen Use and Musculoskeletal Adaptations to Exercise Training in Older Adults.

Jankowski CM, Shea K, Barry DW, Linnebur SA, Wolfe P, Kittelson J, Schwartz RS, Kohrt WM.

Bone Rep. 2015 Jan 1;1:1-8.

15.

Predicting functional performance and range of motion outcomes after total knee arthroplasty.

Bade MJ, Kittelson JM, Kohrt WM, Stevens-Lapsley JE.

Am J Phys Med Rehabil. 2014 Jul;93(7):579-85. doi: 10.1097/PHM.0000000000000065.

16.

Remote source document verification in two national clinical trials networks: a pilot study.

Mealer M, Kittelson J, Thompson BT, Wheeler AP, Magee JC, Sokol RJ, Moss M, Kahn MG.

PLoS One. 2013 Dec 5;8(12):e81890. doi: 10.1371/journal.pone.0081890. eCollection 2013.

17.

Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes.

Van Pelt RE, Gozansky WS, Wolfe P, Kittelson JM, Jankowski CM, Schwartz RS, Kohrt WM.

Obesity (Silver Spring). 2014 Apr;22(4):1024-31. doi: 10.1002/oby.20653. Epub 2013 Dec 6.

18.

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.

Kittelson JM, Spyropoulos AC, Halperin JL, Kessler CM, Schulman S, Steg G, Turpie AG, Cutler NR, Hiatt WR, Goldenberg NA; Antithrombotic Trials Leadership and Steering (ATLAS) Group.

J Thromb Haemost. 2013 Aug;11(8):1443-8. doi: 10.1111/jth.12324. Review.

19.

Amyloid precursor protein is an autonomous growth cone adhesion molecule engaged in contact guidance.

Sosa LJ, Bergman J, Estrada-Bernal A, Glorioso TJ, Kittelson JM, Pfenninger KH.

PLoS One. 2013 May 14;8(5):e64521. doi: 10.1371/journal.pone.0064521. Print 2013.

20.

Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels.

Hildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, Cress ME, Ballard R, Schwartz RS.

J Clin Endocrinol Metab. 2013 May;98(5):1891-900. doi: 10.1210/jc.2012-3695. Epub 2013 Mar 26.

21.

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

Spyropoulos AC, Goldenberg NA, Kessler CM, Kittelson J, Schulman S, Turpie AG, Cutler NR, Hiatt WR, Halperin JL; Antithrombotic Trials Leadership and Steering Group (ATLAS).

J Thromb Haemost. 2012 Dec;10(12):2621-4. doi: 10.1111/jth.12005. No abstract available.

22.

Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.

Boyd AP, Kittelson JM, Gillen DL.

Stat Med. 2012 Dec 10;31(28):3504-15. doi: 10.1002/sim.5440. Epub 2012 Jul 4.

23.

Oral iloprost improves endobronchial dysplasia in former smokers.

Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, Franklin WA, Mao J, Wilson DO, Merrick DT, Hirsch FR, Kennedy TC, Bunn PA Jr, Geraci MW, Miller YE.

Cancer Prev Res (Phila). 2011 Jun;4(6):793-802. doi: 10.1158/1940-6207.CAPR-11-0057.

24.

Fat redistribution following suction lipectomy: defense of body fat and patterns of restoration.

Hernandez TL, Kittelson JM, Law CK, Ketch LL, Stob NR, Lindstrom RC, Scherzinger A, Stamm ER, Eckel RH.

Obesity (Silver Spring). 2011 Jul;19(7):1388-95. doi: 10.1038/oby.2011.64. Epub 2011 Apr 7.

25.

Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?

Lowery JT, Byers T, Kittelson J, Hokanson JE, Mouchawar J, Lewin J, Merrick D, Hines L, Singh M.

Breast Cancer Res Treat. 2011 Aug;129(1):211-9. doi: 10.1007/s10549-011-1448-8. Epub 2011 Mar 24.

26.

Complementary approaches to assessing risk factors for interval breast cancer.

Lowery JT, Byers T, Hokanson JE, Kittelson J, Lewin J, Risendal B, Singh M, Mouchawar J.

Cancer Causes Control. 2011 Jan;22(1):23-31. doi: 10.1007/s10552-010-9663-x. Epub 2010 Oct 27.

PMID:
20978835
27.

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Berger JS, Krantz MJ, Kittelson JM, Hiatt WR.

JAMA. 2009 May 13;301(18):1909-19. doi: 10.1001/jama.2009.623.

PMID:
19436018
28.

A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.

Kelly K, Kittelson J, Franklin WA, Kennedy TC, Klein CE, Keith RL, Dempsey EC, Lewis M, Jackson MK, Hirsch FR, Bunn PA, Miller YE.

Cancer Prev Res (Phila). 2009 May;2(5):440-9. doi: 10.1158/1940-6207.CAPR-08-0136. Epub 2009 Apr 28.

29.

Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.

Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM.

J Clin Endocrinol Metab. 2008 Dec;93(12):4767-73. doi: 10.1210/jc.2007-2614. Epub 2008 Sep 23.

30.

A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.

Jha A, Weintraub A, Allshouse A, Morey C, Cusick C, Kittelson J, Harrison-Felix C, Whiteneck G, Gerber D.

J Head Trauma Rehabil. 2008 Jan-Feb;23(1):52-63. doi: 10.1097/01.HTR.0000308721.77911.ea.

PMID:
18219235
31.

Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.

Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, Byers T, Bunn PA Jr, Lewis MT, Franklin WA, Hirsch FR, Kittelson J.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2425-31.

32.

Frequentist evaluation of group sequential clinical trial designs.

Emerson SS, Kittelson JM, Gillen DL.

Stat Med. 2007 Dec 10;26(28):5047-80.

PMID:
17573678
33.

Bayesian evaluation of group sequential clinical trial designs.

Emerson SS, Kittelson JM, Gillen DL.

Stat Med. 2007 Mar 30;26(7):1431-49.

PMID:
17066402
34.
35.

Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis.

Bhatia SS, Majka DS, Kittelson JM, Parrish LA, Ferucci ED, Deane KD, Arend WP, Rewers M, Michael Holers V, Norris JM.

Ann Rheum Dis. 2007 Feb;66(2):267-9. Epub 2006 Jul 25.

36.

Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.

Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM.

J Clin Endocrinol Metab. 2006 Aug;91(8):2986-93. Epub 2006 May 30.

PMID:
16735495
37.

Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir.

Quan D, Hammack BN, Kittelson J, Gilden DH.

Arch Neurol. 2006 Jul;63(7):940-2. Epub 2006 May 8.

PMID:
16682531
38.

Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.

Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, Kennedy TC, Miller YE, Franklin WA, Hirsch FR.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2281-8.

39.

Group sequential clinical trials for longitudinal data with analyses using summary statistics.

Kittelson JM, Sharples K, Emerson SS.

Stat Med. 2005 Aug 30;24(16):2457-75.

PMID:
15977295
40.

Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.

Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, Hirsch FR, Byers T, Kennedy T, Miller YE, Keith RL, Franklin WA.

Cancer Detect Prev. 2004;28(4):244-51.

PMID:
15350627
41.

Gender differences in lipoprotein lipase activity after acute exercise.

Perreault L, Lavely JM, Kittelson JM, Horton TJ.

Obes Res. 2004 Feb;12(2):241-9.

42.

Weighing evidence: quantitative measures of the importance of bitemark evidence.

Kittelson JM, Kieser JA, Buckingham DM, Herbison GP.

J Forensic Odontostomatol. 2002 Dec;20(2):31-7. Review.

PMID:
12585671
44.

The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control.

Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR.

Am J Respir Crit Care Med. 2001 Sep 1;164(5):738-43.

PMID:
11549525
45.

A unifying family of group sequential test designs.

Kittelson JM, Emerson SS.

Biometrics. 1999 Sep;55(3):874-82.

PMID:
11315020
46.

Statistical methods to improve the precision of the treadmill exercise test.

Stewart RA, Kittelson J, Kay IP.

J Am Coll Cardiol. 2000 Oct;36(4):1274-9.

47.

Collateral recruitment and "warm-up" after first exercise in ischemic heart disease.

Kay IP, Kittelson J, Stewart RA.

Am Heart J. 2000 Jul;140(1):121-5.

PMID:
10874272
48.
49.

Otago glaucoma surgery outcome study: long-term results of trabeculectomy--1976 to 1995.

Molteno AC, Bosma NJ, Kittelson JM.

Ophthalmology. 1999 Sep;106(9):1742-50.

PMID:
10485545
50.

Supplemental Content

Loading ...
Support Center